These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

457 related items for PubMed ID: 10514396

  • 1. Loss of cell cycle regulators p27(Kip1) and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival.
    Del Pizzo JJ, Borkowski A, Jacobs SC, Kyprianou N.
    Am J Pathol; 1999 Oct; 155(4):1129-36. PubMed ID: 10514396
    [Abstract] [Full Text] [Related]

  • 2. Decreasing of p27(Kip1)and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer.
    Kamai T, Takagi K, Asami H, Ito Y, Oshima H, Yoshida KI.
    Br J Cancer; 2001 May 04; 84(9):1242-51. PubMed ID: 11336477
    [Abstract] [Full Text] [Related]

  • 3. Expression of p27(Kip1) protein in transitional cell carcinoma of the upper urinary tract.
    Nakanishi K, Kawai T, Aida S, Kasamatsu H, Aurues T, Ikeda T.
    Mod Pathol; 2001 May 04; 14(5):371-6. PubMed ID: 11353044
    [Abstract] [Full Text] [Related]

  • 4. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1.
    Korkolopoulou P, Christodoulou P, Konstantinidou AE, Thomas-Tsagli E, Kapralos P, Davaris P.
    Hum Pathol; 2000 Jun 04; 31(6):751-60. PubMed ID: 10872671
    [Abstract] [Full Text] [Related]

  • 5. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E, Michael M, Stavropoulos NE, Kitsiou E, Hastazeris K, Salmas M, Stefanaki S, Agnantis NJ.
    Urol Int; 2004 Jun 04; 73(1):65-73. PubMed ID: 15263796
    [Abstract] [Full Text] [Related]

  • 6. Loss of the cyclin-dependent kinase inhibitor p27(Kip1) protein in human prostate cancer correlates with tumor grade.
    Guo Y, Sklar GN, Borkowski A, Kyprianou N.
    Clin Cancer Res; 1997 Dec 04; 3(12 Pt 1):2269-74. PubMed ID: 9815624
    [Abstract] [Full Text] [Related]

  • 7. Minichromosome maintenance proteins 2 and 5 expression in muscle-invasive urothelial cancer: a multivariate survival study including proliferation markers and cell cycle regulators.
    Korkolopoulou P, Givalos N, Saetta A, Goudopoulou A, Gakiopoulou H, Thymara I, Thomas-Tsagli E, Patsouris E.
    Hum Pathol; 2005 Aug 04; 36(8):899-907. PubMed ID: 16112007
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Implication of malignancy and prognosis of p27(kip1), Cyclin E, and Cdk2 expression in epithelial ovarian tumors.
    Sui L, Dong Y, Ohno M, Sugimoto K, Tai Y, Hando T, Tokuda M.
    Gynecol Oncol; 2001 Oct 04; 83(1):56-63. PubMed ID: 11585414
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. P27(Kip1) and Ki-67 expression analysis in transitional cell carcinoma of the bladder.
    Dybowski B, Kupryjańczyk J, Rembiszewska A, Pykało R, Borkowski A.
    Urol Res; 2003 Dec 04; 31(6):397-401. PubMed ID: 14517702
    [Abstract] [Full Text] [Related]

  • 12. Inverse correlation between high level expression of cyclin E and proliferation index in transitional cell carcinoma of the bladder.
    Khan AA, Abel PD, Chaudhary KS, Gulzar Z, Stamp GW, Lalani EN.
    Mol Pathol; 2003 Dec 04; 56(6):353-61. PubMed ID: 14645699
    [Abstract] [Full Text] [Related]

  • 13. Reduced expression of the CDK inhibitor p27(KIP1) in rat two-stage bladder carcinogenesis and its association with expression profiles of p21(WAF1/Cip1) and p53.
    Lee CC, Ichihara T, Yamamoto S, Wanibuchi H, Sugimura K, Wada S, Kishimoto T, Fukushima S.
    Carcinogenesis; 1999 Sep 04; 20(9):1697-708. PubMed ID: 10469613
    [Abstract] [Full Text] [Related]

  • 14. Expression of cell cycle proteins in T1a and T1b urothelial bladder carcinoma and their value in predicting tumor progression.
    Mhawech P, Greloz V, Oppikofer C, Szalay-Quinodoz I, Herrmann F.
    Cancer; 2004 Jun 01; 100(11):2367-75. PubMed ID: 15160340
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Expression of p27 and its ubiquitin ligase subunit Skp2 in upper urinary tract transitional cell carcinoma.
    Langner C, von Wasielewski R, Ratschek M, Rehak P, Zigeuner R.
    Urology; 2004 Sep 01; 64(3):611-6. PubMed ID: 15351619
    [Abstract] [Full Text] [Related]

  • 18. Cyclin-dependent kinase inhibitor P27(KIP1) is expressed preferentially in early stages of urothelial carcinoma.
    Franke KH, Miklosi M, Goebell P, Clasen S, Steinhoff C, Anastasiadis AG, Gerharz C, Schulz WA.
    Urology; 2000 Oct 01; 56(4):689-95. PubMed ID: 11018640
    [Abstract] [Full Text] [Related]

  • 19. Association of cyclin D1 and E1 expression with disease progression and biomarkers in patients with nonmuscle-invasive urothelial cell carcinoma of the bladder.
    Shariat SF, Ashfaq R, Sagalowsky AI, Lotan Y.
    Urol Oncol; 2007 Oct 01; 25(6):468-75. PubMed ID: 18047954
    [Abstract] [Full Text] [Related]

  • 20. Expression of the cyclin-dependent kinase inhibitor p27 in transitional cell bladder cancers: is it a good predictor for tumor behavior?
    Doganay L, Altaner S, Bilgi S, Kaya E, Ekuklu G, Kutlu K.
    Int Urol Nephrol; 2003 Oct 01; 35(2):181-8. PubMed ID: 15072490
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.